6533b85efe1ef96bd12bf36d
RESEARCH PRODUCT
A Trial of a Transglutaminase 2 Inhibitor in Celiac Disease. Reply.
Knut E.a. LundinMarkku MäkiDetlef Schuppansubject
Transglutaminasesbiologybusiness.industryTissue transglutaminaseGeneral MedicineDiseasePharmacologyCeliac DiseaseGTP-binding protein regulatorsGTP-Binding Proteinsbiology.proteinMedicineHumansProtein Glutamine gamma Glutamyltransferase 2business| year | journal | country | edition | language |
|---|---|---|---|---|
| 2021-10-13 | The New England journal of medicine |